Background Recent studies suggest that both endocardial endothelium and coronary vascular endothelium influence myocardial contraction, but the mediators responsible and their mechanisms of action are not well defined.
Methods and Results We investigated the effects of cultured endocardial endothelial and vascular endothelial cell superfusate on contraction and intracellular calcium transients of isolated rat cardiac myocytes. Endothelial cell superfusate induced a potent negative inotropic effect, with a rapid reversible decrease in myocyte twitch amplitude, earlier twitch relaxation, and a significant increase in diastolic length. This effect was not associated with significant changes in intracellular calcium or pH; was not attributable to nitric oxide, prostanoids, cGMP, or protein kinase C activation; and did not V ascular endothelium regulates smooth muscle tone through the coordinated release of dilators such as prostacyclin and endotheliumderived relaxing factor (EDRF or nitric oxide) and constrictors such as endothelin.12 Recent studies indicate that endocardial and coronary vascular endothelium may likewise influence myocardial contraction by releasing diffusible factors.3-8 Both cell types release nitric oxide, which induces negative inotropic effects, and endothelin, which induces positive inotropic effects. 4, 78 However, other unidentified cardioactive substances may also be involved.45, 7 We report here that cultured sheep endocardial endothelial cells (EEC) and vascular endothelial cells (VEC) both exert a novel negative inotropic effect on cardiac myocyte contraction, attributable to a stable unidentified low-molecularweight nonprotein factor that acts predominantly by reducing the response of the myofilaments to calcium.
Methods
Cell Culture EEC were isolated from sheep ventricles by use of 0.1% collagenase (type 1A, Sigma) and plated in medium 199 supplemented with 10% fetal bovine serum, 10% newborn serum IV (Collaborative Research), L-glutamine (2 mmol/L), and antibiotics.9 Sheep pulmonary arterial and aortic VEC were cultured by a similar technique.8 After subculture and passage to flasks, cells from the fifth passage were grown on microcarrier beads. EEC and VEC purity was confirmed both before and after passage to beads by the presence of factor VIII-related antigen and uptake of rhodamine-labeled acetylated low-density lipoprotein in >95% of cells and by the total absence of cytokeratin.9
Myocyte Isolation and Assessment of Function Adult Wistar rat ventricular myocytes were isolated by calcium-free, collagenase retrograde coronary perfusion and kept in HEPES buffer (composition, in with a 0.8-gm filter, and superfused at 1 mL min-1 with HEPES buffer (composition as above) at 37°C. The superfusate was infused directly into a 0.5-mL myocyte chamber at 1 mL * min-l; the transit time from endothelial cell cartridge to myocyte chamber was 45 seconds. The myocyte chamber solution was maintained at 25°C, and pH changes were <0.05 pH units. A control circuit was identical in every respect except for the absence of EC. The measured ionic composition (Na+, K', Cl-, Ca2+, Mg 2+) and osmolality of cell superfusate were unaltered after passage through the cell cartridge, and EC viability (trypan blue exclusion) was also unchanged at the end of the experiments. A total of 16 different batches of EEC/VEC were studied.
Statistics
All data are presented as mean-+-SEM. Within-group comparisons were made by Student's paired t test on absolute data (even when data are presented as percent change) and were considered significant if P<.05.
Results

Effect of EEC and VEC Superfusate on Cardiac Myocytes
Addition of EEC superfusate induced a rapid decrease in twitch amplitude and an increase in diastolic length in all 30 myocytes studied ( Fig 1A) . EEC superfusate effects were rapidly reversed by replacing the chamber solution with HEPES buffer that had passed through the control (cell-free) circuit A reduction in myocyte twitch amplitude without significant change in calcium transient implies a decrease in the response of myofilaments to calcium. Fig  1D depicts the assessment of myofilament response to calcium in a phase-plane plot of instantaneous length versus indo-1 fluorescence for the experiment shown in Fig 1A and 1B. After addition of EC superfusate, the terminal trajectory during twitch relaxation (ie, the "relaxation trajectory") was clearly shifted down (arrow in Fig 1D) Fig 2C, which also demonstrates a large downward shift in relaxation trajectory. In some cases, minor increases or decreases in peak systolic fluorescence were noted. For example, peak systolic fluorescence was slightly increased in the myocytes shown in Fig 2D and 2F , was slightly decreased in the myocyte shown in Fig 1D, but was unaltered in the myocytes shown in Fig 2B and 2C . However, the reduction in twitch amplitude in all cases was clearly a result of decrease in myofilament response to calcium. These findings indicate that EC superfusate exerted cardiac myofilament "desensitizing" activity. In experiments using specific inhibitors of the production and/or activity of prostanoids, nitric oxide, and endothelin (common agents known to be released by EEC as well as VEC4, 8, 9) , the typical activity of EC superfusate was not inhibited ( (4) in the experiments performed with endothelin-1 antiserum, the level of immunoreactive endothelin (measured by radioimmunoassay after removal of endothelin-antibody complex by protein G)8 in the EC superfusate was decreased from 5.7±2.7 to 0.6±0.5 pmol/L (n=4) by the antiserum.
Further studies were performed to investigate the subcellular mechanism of the "myofilament desensitizing" activity. A well-recognized mechanism for reduction in myofilament response to calcium is a reduction in cytosolic pH.17'8 However, in five myocytes loaded with the pH-sensitive fluorescent probe carboxy-seminaphthorhodafluor-1 (SNARF-1)19 and exposed to active EC superfusate, there was no measurable change in cytosolic pH associated with the negative inotropic effect (maximum change, -0.02±0.01 pH units after 5.0±0.8 minutes of exposure to superfusate; P=NS). We have recently observed that myofilament response to calcium may also be reduced by cGMP, acting through activation of cGMP-dependent protein kinase (PKG).20 However, a specific inhibitor of PKG, KT5823 (Calbiochem),21 failed to inhibit EC superfusate activity (Table) . In control experiments, the same dose of KT5823 completely inhibited the negative inotropic effect of 8-bromo cGMP 50 ,umol/L in rat cardiac myocytes (twitch amplitude, -19.6±4.2% with 8-bromo cGMP alone [n=8] versus +8.2±1.5% in the presence of KT5823 [n=4]; P<.05). Neither atrial natriuretic peptide nor C-type natriuretic peptide (Peptide International), two other endothelial agents that elevate cGMP through activation of two different particulate guanylyl cyclases,22 had any detectable effect on myocyte contraction (twitch amplitude, -0.8±2.3% and -2.3+8.1% in six and four myocytes respectively; P=NS). EC superfusate activity was not abolished by
Calbiochem), which inhibits activation of protein kinase C and other kinases, including cAMP-dependent kinase23,24 (Table) . Pretreatment of myocytes with pertussis toxin to inhibit G protein-mediated signal transduction25 was also without effect (Table) . In control experiments, we confirmed that pretreatment of rat myocytes with pertussis toxin (2 ,ug/mL for 3 hours) inhibited the G protein-mediated action of adenosine.25 Thus, in pertussis-untreated myocytes, adenosine 1 ,umol/L inhibited the positive inotropic effects of a f32-adrenergic agonist, Zinterol, 10 gumol/L (twitch amplitude, 109.2±8.8% compared with baseline; n=8), whereas in pertussis-treated myocytes, adenosine had no effect on the positive inotropic effect of Zinterol 10 gLmol/L (twitch amplitude, 341.9±44.7% compared with baseline after Zinterol alone and 339.6±47.6% compared with baseline after Zinterol in the presence of adenosine; n=6; P<.05 comparing pertussis-treated versus pertussis-untreated groups). Discussion We identified a novel negative inotropic activity in the superfusate of cultured EC, presumably a result of a factor released by EC into the superfusing buffer. The "desensitizing factor" typically induced earlier relaxation and a briefer twitch, reduced twitch amplitude, and increased diastolic length of isolated cardiac myocytes without significant associated changes in intracellular calcium transients. An increase in diastolic length of externally unloaded cardiac myocytes implies a reduction in diastolic tone. 13 To the best of our knowledge, this is the first report of a factor released by mammalian cells that exerts myocardial negative inotropic activity predominantly by reducing the response of cardiac myofilaments to calcium. The factor is released by both EEC and VEC but not by a nonendothelial cell type (fibroblasts). Its activity is very stable, it is resistant to protease digestion, and its molecular weight as assessed by membrane ultrafiltration is <<1 kD. These three observations appear to exclude the majority of generally recognized cardioactive or vasoactive substances released by endothelial cells as the likely responsible factor. The possibility that its activity may be due to prostanoids, endothelin, or nitric oxide was excluded. Agents that act by opening potassium channels, eg, the poorly characterized endothelium-derived hyperpolarizing factor, are unlikely to be responsible, because myocyte hyperpolarization would induce secondary changes in the cytosolic calcium transient. 26 In the studies in which we investigated the subcellular mechanism of the negative inotropic activity, the possible involvement of the following second messenger/ signaling pathways was excluded: calcium, pH, nitric oxide, cGMP, protein kinase C, and pertussis toxinsensitive G proteins. Other intracellular agents that modulate myofilament responses to calcium include cAMP, inorganic phosphate, and various phosphatases.17"18 A cAMP-dependent mechanism would raise intracellular calcium and exert positive inotropic effects (which was not observed) unless the rise in cAMP were compartmentalized at the level of the phate occur only during hypoxia or ischemia, which was not the case in the present study. Activation of phosphatases generally occurs secondary to elevation of intracellular calcium or of cyclic nucleotides17'18; neither possibility is likely, as discussed above. Thus, the novel "myofilament-desensitizing" activity we report here appears not to be mediated through commonly recognized second messenger/signaling pathways. This finding considerably strengthens the suspicion that the factor responsible for the activity may be a novel substance.
The unusual pattern of contractile effects observed in the present study, influencing particularly relaxation and diastole, is reminiscent of previous reports of endothelial modulation of contraction in isolated papillary muscle preparations and intact hearts.3-7 In these studies, selective damage of either endocardial endothelium or coronary vascular endothelium resulted in an earlier onset of myocardial relaxation and a reduction in peak isometric force or peak left ventricular pressure, probably by altering the release of cardioactive factors from endothelial cells. The use of multicellular preparations in these studies made it difficult to precisely elucidate either the cell types that released these factors or their intracellular mechanism of action in myocytes. In the present study, the use of single-cell systems enabled us to clearly demonstrate the release of a novel factor both by EEC and VEC and to investigate its subcellular mechanism in some detail. The precise nature of change in myofilament properties (eg, modification of calcium-troponin interaction or of myosin ATPase activity) was not defined, nor was how the reduction in myofilament response to calcium was brought about. Since involvement of common second messenger/signaling pathways was excluded, one possibility is that the desensitizing factor exerts direct effects on the myofilaments. The potency and rapidity of action of the desensitizing factor, its ready reversibility, and its stability suggest that it could exert important modulating effects on myocyte function both locally and distant from its site of production. Preliminary studies indicate that the factor also reduces isometric force in isolated ferret papillary muscles (unpublished observations). However, further studies are required to characterize its effects in these preparations in detail and to determine how its production and release are regulated.
The release of potent cardioactive factors by EEC and VEC adds weight to suggestions that endothelial cells within the heart play an important role in modulating cardiac contraction alongside conventional regulation by neurohumoral agents, loading conditions, and the Frank-Starling mechanism.5-7 Interestingly, modulation of the myofilament response to calcium is the basis of at least part of the effect of a-adrenergic stimulation, as well as the Frank-Starling mechanism, which operates on a beat-to-beat basis. 17 
